Skip to main content

Table 2 Clinical restaging post NACT and histomorphological evaluation

From: Clinical value of hematologic test in predicting tumor response to neoadjuvant chemotherapy with esophageal squamous cell carcinoma

  

Case (n)

%

Response to NACT (radiographic restaging)

  
 

CR

3

7.9

 

PR

24

63.2

 

SD

6

15.8

 

PD

5

13.2

Histomorphological evaluation

  
 

No vital residual tumor cells

2

5.3

 

Decreased vital residual tumor cells with fibrosis

9

23.7

 

No vital post chemotherapy change

14

36.8

 

Metastasis post NACT

1

2.6